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Lysosomes are sites for the degradation of diverse cellular components. We recently discovered novel
lysosomal systems we termed RNautophagy and DNautophagy. In these systems, RNA and DNA,
respectively, are directly imported into lysosomes and degraded. A lysosomal membrane protein,
LAMP2C was identiﬁed as a receptor for these pathways. The short C-terminal cytosolic tail of LAMP2C
binds directly to both RNA and DNA. In this study, we examined the mechanisms underlying recognition
of nucleic acids by the cytosolic sequence of LAMP2C. We found that the sequence possesses features of
the arginine-rich motif, an RNA-recognition motif found in a wide range of RNA-binding proteins.
Substitution of arginine residues in the LAMP2C cytosolic sequence completely abolished its binding
capacity for nucleic acids. A scrambled form of the sequence showed afﬁnity to RNA and DNA equivalent
to that of the wild-type sequence, as is the case for other arginine-rich motifs. We also found that
cytosolic sequences of other LAMP family proteins, LAMP1 and CD68/LAMP4, also possess arginine
residues, and show afﬁnity for nucleic acids. Our results provide further insight into the mechanisms
underlying RNautophagy and DNautophagy, and may contribute to a better understanding of lysosome
function.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Lysosomes are the sites for degradation of various macromole-
cules, such as nucleic acids, proteins, lipids and carbohydrates [1,2].
Processes in which intracellular components are delivered into ly-
sosomes and degraded are called autophagy. To date, at least three
types of autophagy have been identiﬁed: macroautophagy, micro-
autophagy and chaperone-mediated autophagy [3]. In macro-
autophagy, cytosolic components are ﬁrst sequestered by double-
membrane structures called autophagosomes and then delivered
to lysosomes through membrane fusion. In microautophagy, cyto-
solic components are engulfed into lysosomes or late endosomes by
invagination of the lysosomal/endosomal membrane. Chaperone-
mediated autophagy is a process in which cytosolic proteins con-
taining speciﬁc motifs are recognized by the chaperone complexautophagy/DNautophagy.
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membrane receptor, LAMP2A.
We recently discovered novel types of autophagy, which we
termed RNautophagy and DNautophagy [4,5]. In these systems,
nucleic acids are directly imported into the lysosomal lumen in an
ATP-dependent manner. We have also identiﬁed that a lysosomal
membrane protein, LAMP2C, functions, at least in part, as a receptor
for both RNA and DNA in these systems [4,5].
LAMP2C and LAMP2A are splice variants of a major lysosomal
membrane protein, LAMP2 [6]. LAMP2 has a large and highly gly-
cosylated luminal region, a single transmembrane region and a
short C-terminal cytosolic tail consisting of 11e12 amino acid res-
idues. While the luminal region of the three splice variants,
LAMP2A, B and C are identical, the cytosolic tail of each variant has
a distinct sequence [6]. We reported that the cytosolic sequence of
LAMP2C binds directly to both RNA and DNA [4,5]. However, the
mechanism underlying RNA/DNA-recognition by LAMP2C through
this very short cytosolic tail remained undetermined. In this study,
we investigated the amino acid residues in the LAMP2C cytosolic
sequence that are essential for RNA/DNA interactions using peptide
constructs corresponding to wild-type and mutant forms.under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Interactions of puriﬁed RNA and DNA with wild-type and mutant forms of the
cytosolic sequence of LAMP2C. (A) A comparison of cytosolic sequences of human
LAMP2C, B, mouse LAMP2B and human LAMP2A. (B) A schematic of biotin-conjugated
peptide constructs. (C) Interactions of puriﬁed total RNA with wild-type and mutant
forms of the cytosolic sequence of LAMP2C. (D) Interactions of puriﬁed plasmid DNA
(pCI-neo) with wild-type and mutant forms of the cytosolic sequence of LAMP2C.
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2.1. Peptides
Biotin-conjugated peptides were synthesized by Invitrogen or
GenScript custom services.
2.2. Antibodies
The following primary antibodies were used: rabbit polyclonal
anti-RPL8 (LS-C31782, Lifespan), rabbit monoclonal anti-RPS6
(2217, Cell Signaling), mouse monoclonal anti-hnRNP A1 (sc-
365486, Santa Cruz) and mouse monoclonal anti-nucleophosmin
(32-5200, Invitrogen).
2.3. Puriﬁcation of total RNA
Total RNA was puriﬁed from 10- to 12-week-old mouse brains
using TRIzol Reagent (Invitrogen) according to the manufacturer's
instructions. All animal experiments were performed in strict
accordance with the guidelines of the National Institute of Neuro-
science, National Center of Neurology and Psychiatry, and were
approved by the Animal Investigation Committee of the Institute.
2.4. Pull-down assays
Pull-down assays were performed as described previously [4,5],
with slight modiﬁcations. StreptavidineSepharose beads (GE
Healthcare) were blocked with 3% bovine serum albumin for 15 h.
Ten micrograms of puriﬁed total RNA or plasmid DNA (pCI-neo,
Promega), or HeLa cell lysate prepared as described previously [4],
was incubated with 8 nmol of biotin-conjugated peptides and 40 mL
of the beads in PBS containing 0.05% Triton X-100. After incubation
for 90 min at 4 C for assays using puriﬁed RNA and plasmid DNA,
or for 60 min at 4 C in assays using cell lysate, beads were washed
three times with PBS containing 0.05% Triton X-100. RNA pulled
down with the beads was extracted using TRIzol Reagent (Invi-
trogen) according to the manufacturer's instructions. For assays
using DNA, the beads were incubated with 100 mL 1% SDS con-
taining 0.1 mg/mL proteinase K for 90 min at 37 C, and then DNA
was extracted using phenolechloroform. The extracted RNA and
DNA were analyzed by electrophoresis in agarose gels containing
ethidium bromide. For detection of RNA-binding proteins, samples
pulled-down from cell lysate were eluted with SDS-PAGE sample
buffer (10 mM Tris, pH 7.8, 3% SDS, 5% glycerol, 0.02% bromophenol
blue and 2% 2-mercaptoethanol) and analyzed by SDS-PAGE fol-
lowed by immunoblotting or silver staining.
3. Results
Using biotin-conjugated peptide constructs corresponding to
the cytosolic sequence of each LAMP2 variant (LAMP2 peptides),
we have previously reported that the cytosolic sequence of LAMP2C
binds directly to nucleic acids while that of LAMP2A does not show
any afﬁnity for either RNA or DNA, [4,5]. The cytosolic sequence of
LAMP2B, which is more similar to that of LAMP2C compared to
LAMP2A (Fig. 1A), also showed afﬁnity for puriﬁed RNA, although
this was lower than that of LAMP2C [4]. We also reported that the
cytosolic sequence of LAMP2B did not show afﬁnity for DNA [5].
However, in this study, we detected weak binding of LAMP2B to
puriﬁed DNA in a pull-down assay using amodiﬁedmethod (Fig. S1,
see Materials and Methods). Taken together, these observations
indicate that the amino acid residue(s) necessary for RNA and DNA
binding are those that are shared between the cytosolic sequences
of LAMP2C and LAMP2B but not LAMP2A. In human LAMP2C, thereare ﬁve such residues, namely R401, R402, K403, S404 and Q409
(Fig. 1A). However, S404 in human LAMP2C is not conserved in
murine LAMP2B (Fig. 1A), suggesting that S404 may not be neces-
sary for RNA/DNA binding. From these observations, we considered
R401, R402, K403 and Q409 as candidates for RNA/DNA recognition
by LAMP2C (and LAMP2B). Intriguingly, three of the four candi-
dates, R401, R402 and K403 are basic residues. Arginine is the main
component of a common RNA recognition motif, the arginine-rich
motif (ARM) [7,8]. ARM is a short RNA-binding domain (usually
<20 amino acids) with highly basic residues, generally rich in ar-
ginines, found in a variety of RNA-binding proteins [7,8]. Basic re-
gions containing highly conserved arginine residues are also shared
among a wide range of DNA-binding proteins and speciﬁc arginine
residues play essential roles in DNA binding [9e11]. In addition,
glutamine residues are reported to enhance RNA-binding afﬁnity of
ARMs when incorporated into the sequence [12]. From these ob-
servations, we speculated that LAMP2C binds RNA and DNA via an
ARM.
To elucidate the mechanism by which LAMP2C recognizes
nucleic acids, we generated mutant forms of the LAMP2C peptide.
Residues that correspond to R401 and R402, K403 or Q409 in hu-
man LAMP2C were substituted to serine residues (Fig. 1B). Here-
after, we refer to the position of each amino acid residue in the
peptides as positions 1e12, as shown in Fig. 1B. Employing the
wild-type and three mutant forms of the LAMP2C peptide, we ﬁrst
performed pull-down assays using puriﬁed total mouse RNA. The
afﬁnity of the cytosolic sequence of LAMP2C for RNA was
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positions 2 and 3 (Fig. 1C). The afﬁnity to RNA was also partly
attenuated by mutation of the lysine residue at position 4 (Fig. 1C).
Mutation of the glutamine residue at position 10 did not affect the
RNA-binding capacity of the cytosolic sequence of LAMP2C in this
assay (Fig. 1C). The afﬁnity of each peptide to DNA was also
examined using puriﬁed plasmid DNA. The DNA-binding capacity
of the cytosolic sequence of LAMP2C was completely abolished by
mutation of the arginine repeat at positions 2 and 3 or the lysine
residue at position 4 (Fig. 1D). Mutation of the glutamine residue at
position 10 attenuated the DNA-binding capacity (Fig. 1D).
We next performed pull-down assays using these peptides with
HeLa cell lysate, the RNA of which is expected to form complexes
with endogenous RNA-binding proteins [4]. Consistent with the
assay using puriﬁed RNA (Fig. 1C), mutations in the arginine repeat
at positions 2 and 3 completely abolished the afﬁnity of LAMP2C
peptide for RNA (Fig. 2A). Afﬁnity of the peptide for RNAwas almost
completely attenuated by mutation of the lysine residue at position
4, and mutation of the glutamine residue at position 10 also
reduced the afﬁnity of the peptide for RNA (Fig. 2A). These data are
very similar to the results of the assays using DNA (Fig. 1D).
We have previously reported that a variety of RNA-binding
proteins interact indirectly with the cytosolic sequence of
LAMP2C and that this interaction is mediated by RNA [4]. In the
present study, we observed that the interactions of RNA-binding
proteins in the cell lysate to the cytosolic sequence of LAMP2C
were completely abolished by mutations of the arginine repeat at
positions 2 and 3 and of the lysine residue at position 4, and theFig. 2. Interactions of RNA, RNA-binding proteins and total proteins in cell lysate with
wild-type and mutant forms of the cytosolic sequence of LAMP2C. (A) Interactions of
total RNA in HeLa cell lysate with wild-type and mutant forms of the cytosolic
sequence of LAMP2C. (B) Interactions of RNA-binding proteins in HeLa cell lysate with
wild-type and mutant forms of the cytosolic sequence of LAMP2C. (C) Interactions of
total proteins in HeLa cell lysate with wild-type and mutant forms of the cytosolic
sequence of LAMP2C.interactions were reduced by mutation of the glutamine residue at
position 10 (Fig. 2B). These data correlate well with the afﬁnity of
each peptide to RNA in the cell lysate, while silver staining of overall
protein interactions with each peptide was consistent with the
above observations (Fig. 2C).
Synthetic peptides corresponding to the ARM of HIV Tat, an
ARM-containing protein that has been extensively studied, show
the same RNA-binding ability as the wild-type peptide, even when
the amino acid sequence of the peptide was reversed or scrambled
[13]. To assess whether the cytosolic sequence of LAMP2C possesses
a similar feature, we prepared a biotin-conjugated LAMP2C peptide
with a scrambled sequence (Fig. 3A). We performed pull-down
assays using this peptide with puriﬁed RNA and DNA. Of note, the
scrambled peptide showed afﬁnity to both RNA and DNA, equiva-
lent to the wild-type LAMP2C peptide (Fig. 3B and C). These results
suggest that the arrangement of each amino acid residue in the
LAMP2C sequence is not important for RNA/DNA binding and that
other factors, such as overall positive charge, are important, as has
been documented for other ARMs [13,14].
The cytosolic sequence of LAMP2C is completely conserved
among humans, mice and chickens [6]. Furthermore, the cytosolic
sequences of D. melanogaster and C. elegans LAMP orthologs show
the highest level of identity to that of LAMP2C among the three
human LAMP2 variants. Synthetic peptides corresponding to these
sequences also exhibit afﬁnity to RNA/DNA that is comparable to
that of LAMP2C [4,5]. As shown in Fig. 4A, the cytosolic sequences of
both D. melanogaster and C. elegans LAMP orthologs are also rich in
arginine residues. In addition, the cytosolic sequence of the
C. elegans LAMP ortholog contain one lysine and one glutamine
residue (Fig. 4A). These features strongly suggest that D. mela-
nogaster and C. elegans LAMPs also bind to RNA/DNAvia ARMs, in an
analogous manner to LAMP2C. To examine this idea, we prepared a
peptide construct corresponding to the cytosolic sequence of the
C. elegans LAMP ortholog, in which all arginine residues were
substituted to serines (Fig. 4B). We then compared its RNA/DNA-
binding capacity to the wild-type peptide. Both RNA- and DNA-
binding capacities were completely abolished (Fig. 4C and D),
suggesting that the ARM-mediated recognition of nucleic acids by
LAMP family proteins is a mechanism that is evolutionarily
conserved across a wide range of metazoa.Fig. 3. Interactions of puriﬁed RNA and DNA with a scrambled cytosolic sequence of
LAMP2C. (A) A schematic of biotin-conjugated peptide constructs. (B) Interactions of
puriﬁed total RNA with wild-type and scrambled forms of the cytosolic sequence of
LAMP2C. (C) Interactions of puriﬁed plasmid DNA (pCI-neo) with wild-type and
scrambled forms of the cytosolic sequence of LAMP2C.
Fig. 4. Interactions of RNA and DNAwith wild-type and mutant forms of the cytosolic sequence of C. elegans LAMP ortholog and human LAMP family proteins other than LAMP2. (A)
Cytosolic sequences of D. melanogaster and C. elegans LAMP orthologs. (B) A schematic of biotin-conjugated peptide constructs. (C) Interactions of puriﬁed total RNA with wild-type
and mutant forms of cytosolic sequence of C. elegans LAMP. (D) Interactions of puriﬁed plasmid DNA (pCI-neo) with wild-type and mutant forms of cytosolic sequence of C. elegans
LAMP. (E) A schematic of biotin-conjugated peptide constructs. (F) Interactions of puriﬁed total RNA with the cytosolic sequences of human LAMP2C, LAMP1, DC-LAMP and CD68.
(G) Interactions of puriﬁed plasmid DNA (pCI-neo) with the cytosolic sequences of human LAMP2C, LAMP1, DC-LAMP and CD68.
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LAMP1, LAMP2, DC-LAMP/LAMP3, CD68/LAMP4 and BAD-LAMP/
LAMP5. All LAMPs, except for BAD-LAMP, are reported to localize
to lysosomes [6,15e18]. Notably, the short cytosolic tails of all the
proteins possess at least two arginine residues. To assess whether
cytosolic tails of other LAMP family proteins have afﬁnity to nucleic
acids, we generated biotin-conjugated peptides corresponding to
the cytosolic sequences of LAMP1, DC-LAMP and CD68 (Fig. 4E), and
examined their afﬁnity to RNA/DNA. As shown in Fig. 4F and G, the
cytosolic sequence of LAMP1 and CD68 exhibited direct binding to
RNA and DNA, although their afﬁnity to DNAwas much lower than
that of the LAMP2C peptide. The cytosolic sequence of DC-LAMP
scarcely showed afﬁnity for RNA and DNA (Fig. 4F and G).4. Discussion
In this study, we showed that the cytosolic tail of LAMP2C
possesses a distinctive arginine-rich motif and that the arginine
residues in the sequence play a pivotal role in the recognition of
both RNA and DNA. A lysine residue is also important for RNA/DNA-
recognition because the afﬁnity of LAMP2C peptides to nucleic
acids was dramatically attenuated or abolished by substitution of
the lysine residue in all three experiments (Figs. 1e3). These results
are consistent with previous reports describing ARMs in other
proteins.
A glutamine residue appeared to facilitate the afﬁnity of the
sequence, at least for DNA, as substitution of the glutamine residue
resulted in reduced binding of the peptide to puriﬁed DNA (Fig. 1D).
The substitution of glutamine also resulted in reduced afﬁnity of
the sequence for RNA in cell lysate (Fig. 2A), although no alteration
in afﬁnity of the peptide for puriﬁed RNA was detected (Fig. 1C).
A unique feature of arginine relative to other basic amino acids is
that it contains a guanidinium group in its side chain that can form
a hydrogen bond network with the major groove edge of guanineand the backbone phosphate of RNA and DNA [19e22]. It is note-
worthy that arginine residues are not present in the cytosolic
sequence of LAMP2A (Fig. 1A), which does not show any afﬁnity for
nucleic acids [4,5] (see also Fig. S1). LAMP2A is known to function
as a receptor for substrate proteins in chaperone-mediated auto-
phagy, a pathway in which speciﬁc proteins are directly imported
into lysosomes [23]. Binding of the substrate proteins to LAMP2A
has been reported to require a KHHH sequence in the cytosolic tail
of LAMP2A [24], which is also positively charged but devoid of
arginine.
Arginine-rich sequences containing combinations of 12 hydro-
philic or charged amino acids can provide a variety of biologically
functional RNA-binding peptides [12,25,26]. Of note, 10 out of 12
amino acid residues in the cytosolic tail of LAMP2C are among these
12 hydrophilic or charged amino acids. The other two residues are a
conserved tyrosine residue necessary for the YXXФ lysosomal tar-
geting signal and a valine residue, also necessary for the YXXФ
motif as a hydrophobic residue [27]. The fact that the cytosolic
sequence of LAMP2C alone as a synthetic peptide can bind RNA is
also a common feature shared among a variety of ARMs [8].
ARMs generally show relatively high speciﬁcity in their RNA
binding [8], although binding of ARMs to RNA without apparent
sequence speciﬁcity has also been reported [28]. As we have pre-
viously reported [4], and as shown in Fig. 1C, the cytosolic sequence
of LAMP2C can bind to almost all total RNA; however, RNA of low
molecular weight appears to have lower or no afﬁnity to the
sequence [4] (see also Fig.1C).Whether the cytosolic tail of LAMP2C
has any speciﬁcity in its binding to RNA/DNA remains to be
addressed.
Although cytosolic sequences of both LAMP2B and LAMP2C bind
to RNA/DNA, the afﬁnity of the LAMP2C peptide to nucleic acids is
higher than that of the LAMP2B peptide [4,5] (see also Fig. S1). It is
noteworthy that LAMP2C possesses an additional arginine residue
in its cytosolic tail, where a tyrosine residue is located in LAMP2B
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is sufﬁcient for RNA binding, and surrounding basic amino acids
such as additional arginines and lysines enhance the afﬁnity of the
motif for RNA and the kinetic stability of the proteineRNA complex
[8,29]. The fact that a scrambled form of the LAMP2C peptide binds
RNA/DNA with equally afﬁnity to the wild-type peptide suggests
that it is not the arrangement but the components of the sequence
that is important for binding. The additional arginine residue in the
cytosolic sequence of LAMP2C may be responsible for the higher
afﬁnity of the sequence for nucleic acids.
In previous studies, we showed that RNA and DNA are directly
imported into lysosomes in anATP-dependentmanner and degraded
[4,5].We identiﬁedLAMP2Cas at least oneof the receptors fornucleic
acid substrates in these pathways, RNautophagy and DNautophagy.
However, lysosomes isolated from Lamp2 knockout mice showed
only partly attenuated levels of RNautophagy/DNautophagy (here-
after abbreviated as RDA) [4,5], indicating the existence of LAMP2-
independent pathways in these systems. In the present study, we
found that cytosolic sequences of LAMP1 and CD68 also directly bind
RNA and DNA. Although the afﬁnity of these sequences for DNA is
weaker than thatof LAMP2C, LAMPfamilyproteinsother thanLAMP2
are attractive candidates as novel RDA-related genes.
Although ARMs are present in wide range of species across
diverse phyla, they are commonly found in viral proteins and often
play essential roles in viral replication processes [7,8]. In particular,
HIV-1 Rev and HTLV-I Rex proteins, which possess ARMs, function
in transporting viral mRNA to the cytoplasm [7,8]. It is possible that
RNautophagy may block such processes by capturing viral RNAs via
the RNA-recognition mechanism of the cytosolic tails of lysosomal
receptors. Physiological roles of RDA mediated by ARMs are an
intriguing issue for future research.
The precise mechanisms of RNA/DNA transport in RDA are still
largely unknown. It is interesting that ARMs of HIV-1 Rev protein
and Tat protein (RQARRNRRRRWRERQR and YGRKKRRQRRRP,
respectively) induce conformational change in the RNAs that they
bind [13,30]. Likewise, conformational change of substrate nucleic
acids by the cytosolic tail of LAMP2C (or other receptors) may take
place in the translocation process of RDA. In addition, the Tat ARM
is unstructured in the unbound state, and becomes partially or fully
structured when bound to RNA [13]. Structural change in the DNA-
binding basic region of the transcription factor TFEB (LAKE-
RQKKDNHNLIERRRR) upon binding to DNA has also been reported
[31]. Structural change in the cytosolic tail of LAMP2C or other re-
ceptors may also occur in the process of RDA, for instance to pass
substrate nucleic acids to other as yet unknown factors involved in
RDA, such as transporters or ATPases.
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